Inventisbio
Shanghai, CN · Founded 2013 · 32 employees on LinkedIn · 4 known investors
InventisBio is a China-based drug discovery company developing patent-protected small-molecule targeted therapies for oncology and metabolic diseases. Its pipeline addresses solid tumors such as non-small cell lung, breast, and colorectal cancer, as well as hyperuricemia/gout and autoimmune conditions like psoriasis.
Founders & leadership
Inventisbio was founded in 2013 by Xing Dai and Yaolin Wang.
Investors · 4
Frequently asked questions
- What does Inventisbio do?
- InventisBio is a China-based drug discovery company developing patent-protected small-molecule targeted therapies for oncology and metabolic diseases. Its pipeline addresses solid tumors such as non-small cell lung, breast, and colorectal cancer, as well as hyperuricemia/gout and autoimmune conditions like psoriasis.
- Who founded Inventisbio?
- Inventisbio was founded by Xing Dai, Yaolin Wang in 2013.
- Who are Inventisbio's investors?
- Inventisbio's investors include LAV, Lilly Asia Ventures, OrbiMed, Qiming Venture Partners.
- Where is Inventisbio headquartered?
- Inventisbio is headquartered in Shanghai, CN.